Page 4

from the editor

Publisher Guy Bertuzzi, guy@elevatenv.com

Editor-In-Chief Beth Schwartz, beth@elevatenv.com

Creative Director Brooke Bertuzzi, brooke@finetheagency.com

Contributing Writers:Justin Alexander, Kayla Anderson, Josh Bell, Amanda Connor, Deborah Costella, Celena Esquer, Natice Locke Media Consultants: Mark Damkroeger, mark@elevatenv.com Marissa Skinner, marissa@elevatenv.com Nicole Verlinich, nicole@elevatenv.com

ELEVATION PUBLISHING LLC Chief Financial Officer Cassandra Lupo

FINE THE AGENCY Partner Kelli Maruca, kelli@finetheagency.com

Graphic Designer James Nigbur, james@finetheagency.com

Account Coordinator Kimberly Chang, kim@finetheagency.com elevate nevada magazine makes every effort to ensure the accuracy of the information it publishes, but cannot be held responsible for any consequences arising from errors, false data or omissions. elevate nevada assumes no responsibility for any claims or representations contained in this publication or in any advertisement. elevate nevada magazine does not encourage the illegal use of any of the products or advertisements within. Reproduction in whole or in part strictly prohibited. All rights reserved. To subscribe to elevate nevada, visit elevatenv.com/subscribe/. 7120 Rafael Ridge Way, Las Vegas, NV 89119 Phone: 702.855.3843 | Email: info@elevatenv.com

elevateNV

elevateNevada

CBD is currently enjoying a big ole, blissinducing moment in the spotlight. After years of being overshadowed by cannabis’ most celebrated superstar— the sometimes paranoid and always psychoactive THC—the beatific and subdued healer CBD seems to have finally edged itself back on to the world’s stage to find a slice of the everincreasing pro-cannabis limelight. Interestingly, cannabidiol was on the scene long before tetrahydrocannabinol. It was discovered in 1940 by Dr. Roger Adams and his team at the University of Illinois. While Israeli researcher Raphael Mechoulam and his colleagues at Hebrew University of Jerusalem didn’t discover THC’s star power until decades later in 1964. After being cast aside as a no-talent, devoid of healing properties, in favor of the more dramatic and overacting (if there ever was one in the cannabinoid family tree) THC, the always subtle CBD has finally started getting its due. Cannabidiol, which offers relief from inflammation, pain, anxiety, psychosis, seizures, and spasms, began to build notoriety last year. It started with booths popping up at farmers markets and art fairs where the benefits of CBD salves and lotions were touted for the relief of maladies that included arthritis, fibromyalgia, and chronic pain. Since the calendar flipped to 2018, it seems CBD has finally begun to find the fame and fortune it’s so deserving of receiving. It’s been making a meteoric career turn, breaking away from being known for starring roles in tinctures, lotions, salves, bath bombs and balms to appearing in food items that range from wine, tea, and cold-brew coffee to gummies, honey, and smoothies. Part of CBD’s rising star status is a result of the 2014 U.S. Farm Bill,

which outlines that a state’s Department of Agriculture may grow or cultivate industrial hemp. Nevada’s political leaders didn’t waste any time in seeing the potential and passed Senate Bill 305 in 2015 which allowed hemp cultivation in the state under current federal guidelines. With over 20 states signing on to similar legislation, this has created a big boon in CBD oil production that has resulted in a dizzying array of products. But be careful about the CBD products you purchase. There are enough bad actors in the marketplace posing as CBD-dominant products that the FDA has taken notice. The federal agency tests products that claim to have cannabidiol to ensure their accuracy. (You can find the FDA’s list of products that don’t contain the levels of CBD claimed on the label at https://www.fda.gov/NewsEvents/ PublicHealthFocus/ucm484109.htm) The FDA and I have not been the only ones to notice CBD’s recent popularity. In March cannabidiol made a grand debut at Natural Products Expo West when the massive trade show hosted its first-ever CBD Summit. According to a report in the Cannabist, the expo’s goal was to provide a glimpse of the products made with the hemp-based extract. The Washington Post called CBD "the new ‘it’ drug." Quartzy declared that it is a "rapidly rising star for its capacity to deliver mental and physical benefits," which was reported under a headline calling CBD “the next big thing.” We think the next big thing already arrived. Cheers to rising stars, stars and stripes, and the freedom to elevate,

Profile for Elevate Nevada Magazine

Elevate july 2018  

Elevate july 2018  

Profile for elevatenv
Advertisement